Physician

Jeffrey S Delo, MD

According to 2025 Medicare claims, Jeffrey Delo, MD (NPI: 1295776383) practices hematology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Anderson, SC. This provider's primary affiliated billing organization is ANDERSON ONCOLOGY-HEMATOLOGY CLINIC PA (NPI: 1316914161; TIN: 570749974) and primary practice location at 29621-1580. Delo is affiliated with the Southeastern Health Partners (ACO ID: A3325), participating under the MSSP model.

Delo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 451 traditional Medicare patients, billed 145,370 HCPCS/CPT codes, and received $1,942,217 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,146 prescription claims across 391 beneficiaries totaling $3,164,630 in drug costs, led by Xtandi (Enzalutamide). 2023 DME data shows 74 claims. Open Payments data shows 169 records totaling $4,798. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,570,259 to $1,942,217. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $986,057 to $3,164,630. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $8,903 and ending at $11,574.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$971K$1.9M2015 Medicare payment: $1,570,259 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,217,170 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $68,474 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $72,268 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $111,525 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $114,782 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $169,723 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $247,942 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,658,537 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,942,217 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015672139,682$1,570,259
2016733103,739$1,217,170
20172841,557$68,474
20182591,264$72,268
20193631,805$111,525
20203971,781$114,782
20214422,038$169,723
20224517,542$247,942
202340296,267$1,658,537
2024451145,370$1,942,217

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.2M2015 Drug cost: $986,057 (USD; Tot_Drug_Cst)2016 Drug cost: $1,078,447 (USD; Tot_Drug_Cst)2017 Drug cost: $464,365 (USD; Tot_Drug_Cst)2018 Drug cost: $732,089 (USD; Tot_Drug_Cst)2019 Drug cost: $1,397,755 (USD; Tot_Drug_Cst)2020 Drug cost: $1,557,433 (USD; Tot_Drug_Cst)2021 Drug cost: $1,244,672 (USD; Tot_Drug_Cst)2022 Drug cost: $2,575,198 (USD; Tot_Drug_Cst)2023 Drug cost: $2,831,090 (USD; Tot_Drug_Cst)2024 Drug cost: $3,164,630 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152281,886$986,057
20162691,869$1,078,447
2017193784$464,365
2018124810$732,089
2019142858$1,397,755
2020155856$1,557,433
20212731,147$1,244,672
20223602,084$2,575,198
20234012,137$2,831,090
20243912,146$3,164,630

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$38K$75K2015 Medicare payment: $75,305 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $44,431 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,777 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $7,174 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $645 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,092 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $21,731 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R164$75,305
201639227$44,431
2017N/R87$2,777
2018N/R79$7,174
2019N/RN/RN/R
2020N/R12$645
2021N/R24$1,092
2022N/RN/RN/R
20231574$21,731
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more347936$93
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's352882$13
80053Blood test, comprehensive group of blood chemicals4081,678$10
36415Insertion of needle into vein for collection of blood sample208416$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4051,699$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XtandiEnzalutamide341,020$463,230
RevlimidLenalidomide24637$463,149
ImbruvicaIbrutinib25722$274,949
KisqaliRibociclib Succinate14392$221,915
BrukinsaZanubrutinib11330$150,762

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.169$4,798Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey S. Delo, MD?

Tedicare shows public-source Medicare data for Jeffrey S. Delo, MD (NPI 1295776383), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey S. Delo, MD have ACO affiliation data?

Jeffrey S. Delo, MD is shown with ACO affiliation data for Southeastern Health Partners (MSSP, ACO ID A3325).

What billing organization is linked to Jeffrey S. Delo, MD?

Jeffrey S. Delo, MD is linked to ANDERSON ONCOLOGY-HEMATOLOGY CLINIC PA (billing NPI 1316914161) in the available physician profile data.

Does Jeffrey S. Delo, MD have Open Payments data?

Jeffrey S. Delo, MD has 169 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.